Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death
Gustavo E. Velásquez(Brigham and Women's Hospital), Salmaan Keshavjee(Brigham and Women's Hospital), Yevgeniy G. Andreev, Carole D. Mitnick(Brigham and Women's Hospital), Michael Rich, Sonya Shin(Brigham and Women's Hospital), Molly F. Franke(Harvard University), G. V. Yanova, M. C. Becerra(Harvard University), S Atwood, Askar Yedilbayev(World Health Organization Regional Office for Europe), Irina Gelmanova, Alexander Pasechnikov
Cited by 51
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|321
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe
|European Respiratory Journal|2019|130